Guardian Pharmacy Services, Inc. (GRDN) 10-Year Financial Performance & Capital Metrics

GRDN • • Industrial / General

HealthcareMedical DistributionSpecialty Pharmacy ServicesLong-Term Care Pharmacy Services

AboutGuardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.Show more

Revenue $1.23B +17.4%
EBITDA -$43M -172.9%
Net Income -$87M -465.2%
EPS (Diluted) -1.77 -553.8%
Gross Margin 19.89%
EBITDA Margin -3.51% -162.1%
Operating Margin -5.12% -230.9%
Net Margin -7.11% -411.0%
ROE -83.2% -336.3%
ROIC -30.36% -231.7%
Debt/Equity 0.25 -78.5%
Interest Coverage -19.19 -234.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 12.0%
✓Efficient asset utilization: 3.8x turnover

✗Weaknesses

✗Weak 3Y average ROE of 2.3%
✗Thin 5Y average net margin of 0.8%
✗Expensive at 12.2x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y11.96%

3Y15.75%

TTM18.68%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM146.14%

EPS CAGR

10Y-

5Y-

3Y-

TTM133.16%

ROCE

10Y Avg18.72%

5Y Avg15.64%

3Y Avg9.22%

Latest-40.61%

Peer Comparison

Long-Term Care Pharmacy Services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
GRDNGuardian Pharmacy Services, Inc.	1.07B	29.50	-16.67	17.42%	2.9%	20.58%	3.89%	0.25

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	600.37M	698.29M	735.96M	792.07M	908.91M	1.05B	1.23B
Revenue Growth %	-	0.16%	0.05%	0.08%	0.15%	0.15%	0.17%
Cost of Goods Sold+	477.33M	554.83M	588.96M	630.81M	723.04M	837.88M	984.04M
COGS % of Revenue	0.8%	0.79%	0.8%	0.8%	0.8%	0.8%	0.8%
Gross Profit+	123.03M	143.46M	147M	161.26M	185.87M	208.31M	244.37M
Gross Margin %	0.2%	0.21%	0.2%	0.2%	0.2%	0.2%	0.2%
Gross Profit Growth %	-	0.17%	0.02%	0.1%	0.15%	0.12%	0.17%
Operating Expenses+	97.1M	109.36M	114.94M	131.12M	133.88M	167.36M	307.29M
OpEx % of Revenue	0.16%	0.16%	0.16%	0.17%	0.15%	0.16%	0.25%
Selling, General & Admin	87.84M	97.56M	102.54M	131.12M	133.88M	167.36M	307.29M
SG&A % of Revenue	0.15%	0.14%	0.14%	0.17%	0.15%	0.16%	0.25%
Research & Development	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-
Other Operating Expenses	9.26M	11.8M	12.4M	0	0	0	0
Operating Income+	25.93M	34.1M	32.06M	30.15M	51.99M	40.95M	-62.92M
Operating Margin %	0.04%	0.05%	0.04%	0.04%	0.06%	0.04%	-0.05%
Operating Income Growth %	-	0.31%	-0.06%	-0.06%	0.72%	-0.21%	-2.54%
EBITDA+	39.06M	49.95M	49.32M	46.68M	68.55M	59.18M	-43.15M
EBITDA Margin %	0.07%	0.07%	0.07%	0.06%	0.08%	0.06%	-0.04%
EBITDA Growth %	-	0.28%	-0.01%	-0.05%	0.47%	-0.14%	-1.73%
D&A (Non-Cash Add-back)	13.13M	15.85M	17.26M	16.53M	16.56M	18.23M	19.77M
EBIT	25.17M	33.62M	31.82M	29.96M	51.59M	40.58M	-63.2M
Net Interest Income+	-1.9M	-2.25M	-2.16M	-1.64M	-1.93M	-2.86M	-3.28M
Interest Income	0	0	0	0	0	0	0
Interest Expense	1.9M	2.25M	2.16M	1.64M	1.93M	2.86M	3.28M
Other Income/Expense	-2.66M	-2.73M	-2.4M	-1.82M	-2.33M	-3.23M	-3.56M
Pretax Income+	23.27M	31.37M	29.66M	28.33M	49.66M	37.72M	-66.48M
Pretax Margin %	0.04%	0.04%	0.04%	0.04%	0.05%	0.04%	-0.05%
Income Tax+	0	0	0	0	0	0	4.56M
Effective Tax Rate %	0.63%	0.69%	0.67%	0.58%	0.71%	0.63%	1.31%
Net Income+	14.68M	21.75M	19.94M	16.31M	35.42M	23.9M	-87.29M
Net Margin %	0.02%	0.03%	0.03%	0.02%	0.04%	0.02%	-0.07%
Net Income Growth %	-	0.48%	-0.08%	-0.18%	1.17%	-0.33%	-4.65%
Net Income (Continuing)	23.27M	31.37M	29.66M	28.33M	49.66M	37.72M	-71.03M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	25.86M	27.72M	28.59M	29.39M	33.2M	31.65M	7.3M
EPS (Diluted)+	0.24	0.36	0.33	0.27	0.58	0.39	-1.77
EPS Growth %	-	0.5%	-0.08%	-0.18%	1.15%	-0.33%	-5.54%
EPS (Basic)	0.24	0.36	0.33	0.27	0.58	0.39	-1.77
Diluted Shares Outstanding	60.84M	60.84M	60.84M	60.84M	60.84M	60.84M	62.01M
Basic Shares Outstanding	60.84M	60.84M	60.84M	60.84M	60.84M	60.84M	62.01M
Dividend Payout Ratio	1.56%	1.15%	0.54%	1.06%	0.87%	1.61%	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	81.23M	90.08M	93.82M	111.87M	120M	129.6M	151.99M
Cash & Short-Term Investments	2.25M	275K	6.45M	15.01M	607K	752K	4.66M
Cash Only	2.25M	275K	6.45M	15.01M	607K	752K	4.66M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	47.66M	54.21M	45.78M	55.25M	67.83M	77.26M	97.15M
Days Sales Outstanding	28.97	28.34	22.7	25.46	27.24	26.96	28.87
Inventory	27.54M	30.94M	31.93M	33.09M	41.44M	36.73M	40.55M
Days Inventory Outstanding	21.06	20.35	19.79	19.15	20.92	16	15.04
Other Current Assets	3.78M	4.66M	2.89M	8.52M	10.12M	14.86M	9.62M
Total Non-Current Assets+	100.58M	106.43M	124.05M	123.98M	136.12M	141.56M	168.82M
Property, Plant & Equipment	27.98M	35.41M	51.98M	51.72M	65.19M	73.18M	78.96M
Fixed Asset Turnover	21.46x	19.72x	14.16x	15.31x	13.94x	14.30x	15.56x
Goodwill	47.82M	46.33M	52.45M	54.63M	56.05M	56.05M	69.3M
Intangible Assets	23.82M	20.69M	19.11M	17.09M	14.44M	11.98M	14.91M
Long-Term Investments	0	0	0	0	0	0	0
Other Non-Current Assets	953K	4.01M	505K	529K	435K	358K	5.66M
Total Assets+	181.81M	196.51M	217.87M	235.85M	256.11M	271.17M	320.81M
Asset Turnover	3.30x	3.55x	3.38x	3.36x	3.55x	3.86x	3.83x
Asset Growth %	-	0.08%	0.11%	0.08%	0.09%	0.06%	0.18%
Total Current Liabilities+	65.27M	90.19M	86.35M	111.54M	112M	138.01M	144.12M
Accounts Payable	47.53M	54.93M	53.41M	64.62M	78.1M	85.6M	102.42M
Days Payables Outstanding	36.34	36.14	33.1	37.39	39.43	37.29	37.99
Short-Term Debt	2.64M	17.04M	3.63M	3.71M	7.96M	12.98M	0
Deferred Revenue (Current)	0	0	0	0	0	0	0
Other Current Liabilities	7.68M	9.94M	0	20.42M	3.62M	12.33M	16.65M
Current Ratio	1.24x	1.00x	1.09x	1.00x	1.07x	0.94x	1.05x
Quick Ratio	0.82x	0.66x	0.72x	0.71x	0.70x	0.67x	0.77x
Cash Conversion Cycle	13.69	12.55	9.39	7.21	8.73	5.66	5.92
Total Non-Current Liabilities+	48.53M	49.28M	64.44M	70.99M	68.18M	73.29M	26.71M
Long-Term Debt	36.37M	33.66M	30.74M	26.99M	22.97M	18.99M	0
Capital Lease Obligations	2.35M	3.59M	15.54M	16.12M	23.67M	27.04M	26.71M
Deferred Tax Liabilities	0	0	0	0	0	0	0
Other Non-Current Liabilities	9.81M	12.03M	18.16M	27.88M	21.54M	27.26M	0
Total Liabilities	113.8M	139.47M	150.8M	182.53M	180.18M	211.31M	170.83M
Total Debt+	43.71M	57.12M	58.84M	55.04M	62.98M	69.15M	37.33M
Net Debt	41.46M	56.84M	52.39M	40.03M	62.38M	68.4M	32.67M
Debt / Equity	0.73x	2.06x	0.88x	1.03x	0.83x	1.16x	0.25x
Debt / EBITDA	1.12x	1.14x	1.19x	1.18x	0.92x	1.17x	-
Net Debt / EBITDA	1.06x	1.14x	1.06x	0.86x	0.91x	1.16x	-
Interest Coverage	13.65x	15.15x	14.87x	18.42x	26.99x	14.32x	-19.19x
Total Equity+	59.89M	27.72M	67.07M	53.32M	75.93M	59.86M	149.98M
Equity Growth %	-	-0.54%	1.42%	-0.21%	0.42%	-0.21%	1.51%
Book Value per Share	0.98	0.46	1.10	0.88	1.25	0.98	2.42
Total Shareholders' Equity	34.03M	0	38.48M	23.93M	42.73M	28.21M	142.67M
Common Stock	34.03M	29.95M	39.15M	24.11M	42.73M	28.21M	63K
Retained Earnings	0	0	0	0	0	0	17.12M
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	-386K	-630K	-676K	-185K	0	0	0
Minority Interest	25.86M	27.72M	28.59M	29.39M	33.2M	31.65M	7.3M

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	43.67M	56.16M	52.61M	58.5M	48.52M	70.82M	57.96M
Operating CF Margin %	0.07%	0.08%	0.07%	0.07%	0.05%	0.07%	0.05%
Operating CF Growth %	-	0.29%	-0.06%	0.11%	-0.17%	0.46%	-0.18%
Net Income	23.27M	31.37M	29.66M	28.33M	49.66M	37.72M	-71.03M
Depreciation & Amortization	13.13M	15.85M	17.26M	16.53M	16.56M	18.23M	19.77M
Stock-Based Compensation	5.98M	1.93M	3.21M	13.03M	-3.38M	-6.09M	131.49M
Deferred Taxes	0	0	0	0	0	0	0
Other Non-Cash Items	2.95M	5.67M	3.58M	2.08M	4.4M	5.35M	7.14M
Working Capital Changes	-1.66M	1.34M	-1.09M	-1.47M	-18.72M	15.6M	-29.41M
Change in Receivables	-8.79M	-11.13M	3.58M	-7.71M	-16.79M	-14.3M	-25.48M
Change in Inventory	475K	-3.05M	379K	-240K	-8.12M	4.43M	-1.15M
Change in Payables	9.05M	7.91M	-1.95M	9.78M	13.37M	6.29M	13.23M
Cash from Investing+	-20.75M	-16.59M	-12.18M	-13.15M	-17.9M	-13.44M	-30.41M
Capital Expenditures	-10.01M	-14.54M	-8.34M	-9.28M	-16.77M	-14.56M	-16.37M
CapEx % of Revenue	0.02%	0.02%	0.01%	0.01%	0.02%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	-57K	16K	545K	535K	874K	2.1M	671K
Cash from Financing+	-21.07M	-41.55M	-34.26M	-36.79M	-45.03M	-57.23M	-23.64M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	-27.99M	-34.32M	-10.82M	-17.36M	-30.8M	-38.42M	-35.75M
Share Repurchases	-	-	-	-	-	-	-
Other Financing	-9.11M	-9.52M	-10.07M	-13.34M	-11.42M	-15.92M	-16.02M
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	33.67M	41.62M	44.27M	49.22M	31.75M	56.26M	41.59M
FCF Margin %	0.06%	0.06%	0.06%	0.06%	0.03%	0.05%	0.03%
FCF Growth %	-	0.24%	0.06%	0.11%	-0.35%	0.77%	-0.26%
FCF per Share	0.55	0.68	0.73	0.81	0.52	0.92	0.67
FCF Conversion (FCF/Net Income)	2.98x	2.58x	2.64x	3.59x	1.37x	2.96x	-0.66x
Interest Paid	1.83M	2.25M	2.08M	1.52M	1.78M	2.78M	3.12M
Taxes Paid	0	0	0	0	0	0	0

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	24.51%	49.64%	42.08%	27.1%	54.81%	35.2%	-83.2%
Return on Invested Capital (ROIC)	-	27.51%	23.57%	21.25%	33.66%	23.04%	-30.36%
Gross Margin	20.49%	20.54%	19.97%	20.36%	20.45%	19.91%	19.89%
Net Margin	2.44%	3.11%	2.71%	2.06%	3.9%	2.28%	-7.11%
Debt / Equity	0.73x	2.06x	0.88x	1.03x	0.83x	1.16x	0.25x
Interest Coverage	13.65x	15.15x	14.87x	18.42x	26.99x	14.32x	-19.19x
FCF Conversion	2.98x	2.58x	2.64x	3.59x	1.37x	2.96x	-0.66x
Revenue Growth	-	16.31%	5.39%	7.62%	14.75%	15.1%	17.42%

Revenue by Segment

	2024
Corporate	1.23B
Corporate Growth	-

Frequently Asked Questions

Growth & Financials

Guardian Pharmacy Services, Inc. (GRDN) reported $1.39B in revenue for fiscal year 2024. This represents a 131% increase from $600.4M in 2018.

Guardian Pharmacy Services, Inc. (GRDN) grew revenue by 17.4% over the past year. This is strong growth.

Yes, Guardian Pharmacy Services, Inc. (GRDN) is profitable, generating $40.2M in net income for fiscal year 2024 (-7.1% net margin).

Dividend & Returns

Yes, Guardian Pharmacy Services, Inc. (GRDN) pays a dividend with a yield of 1.95%. This makes it attractive for income-focused investors.

Guardian Pharmacy Services, Inc. (GRDN) has a return on equity (ROE) of -83.2%. Negative ROE indicates the company is unprofitable.

Guardian Pharmacy Services, Inc. (GRDN) generated $45.2M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Guardian Pharmacy Services, Inc. (GRDN) 10-Year Financial Performance & Capital Metrics

GRDN • • Industrial / General

HealthcareMedical DistributionSpecialty Pharmacy ServicesLong-Term Care Pharmacy Services

Revenue $1.23B +17.4%
EBITDA -$43M -172.9%
Net Income -$87M -465.2%
EPS (Diluted) -1.77 -553.8%
Gross Margin 19.89%
EBITDA Margin -3.51% -162.1%
Operating Margin -5.12% -230.9%
Net Margin -7.11% -411.0%
ROE -83.2% -336.3%
ROIC -30.36% -231.7%
Debt/Equity 0.25 -78.5%
Interest Coverage -19.19 -234.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 12.0%
✓Efficient asset utilization: 3.8x turnover

✗Weaknesses

✗Weak 3Y average ROE of 2.3%
✗Thin 5Y average net margin of 0.8%
✗Expensive at 12.2x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y11.96%

3Y15.75%

TTM18.68%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM146.14%

EPS CAGR

10Y-

5Y-

3Y-

TTM133.16%

ROCE

10Y Avg18.72%

5Y Avg15.64%

3Y Avg9.22%

Latest-40.61%

Peer Comparison

Long-Term Care Pharmacy Services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
GRDNGuardian Pharmacy Services, Inc.	1.07B	29.50	-16.67	17.42%	2.9%	20.58%	3.89%	0.25

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	600.37M	698.29M	735.96M	792.07M	908.91M	1.05B	1.23B
Revenue Growth %	-	0.16%	0.05%	0.08%	0.15%	0.15%	0.17%
Cost of Goods Sold+	477.33M	554.83M	588.96M	630.81M	723.04M	837.88M	984.04M
COGS % of Revenue	0.8%	0.79%	0.8%	0.8%	0.8%	0.8%	0.8%
Gross Profit+	123.03M	143.46M	147M	161.26M	185.87M	208.31M	244.37M
Gross Margin %	0.2%	0.21%	0.2%	0.2%	0.2%	0.2%	0.2%
Gross Profit Growth %	-	0.17%	0.02%	0.1%	0.15%	0.12%	0.17%
Operating Expenses+	97.1M	109.36M	114.94M	131.12M	133.88M	167.36M	307.29M
OpEx % of Revenue	0.16%	0.16%	0.16%	0.17%	0.15%	0.16%	0.25%
Selling, General & Admin	87.84M	97.56M	102.54M	131.12M	133.88M	167.36M	307.29M
SG&A % of Revenue	0.15%	0.14%	0.14%	0.17%	0.15%	0.16%	0.25%
Research & Development	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-
Other Operating Expenses	9.26M	11.8M	12.4M	0	0	0	0
Operating Income+	25.93M	34.1M	32.06M	30.15M	51.99M	40.95M	-62.92M
Operating Margin %	0.04%	0.05%	0.04%	0.04%	0.06%	0.04%	-0.05%
Operating Income Growth %	-	0.31%	-0.06%	-0.06%	0.72%	-0.21%	-2.54%
EBITDA+	39.06M	49.95M	49.32M	46.68M	68.55M	59.18M	-43.15M
EBITDA Margin %	0.07%	0.07%	0.07%	0.06%	0.08%	0.06%	-0.04%
EBITDA Growth %	-	0.28%	-0.01%	-0.05%	0.47%	-0.14%	-1.73%
D&A (Non-Cash Add-back)	13.13M	15.85M	17.26M	16.53M	16.56M	18.23M	19.77M
EBIT	25.17M	33.62M	31.82M	29.96M	51.59M	40.58M	-63.2M
Net Interest Income+	-1.9M	-2.25M	-2.16M	-1.64M	-1.93M	-2.86M	-3.28M
Interest Income	0	0	0	0	0	0	0
Interest Expense	1.9M	2.25M	2.16M	1.64M	1.93M	2.86M	3.28M
Other Income/Expense	-2.66M	-2.73M	-2.4M	-1.82M	-2.33M	-3.23M	-3.56M
Pretax Income+	23.27M	31.37M	29.66M	28.33M	49.66M	37.72M	-66.48M
Pretax Margin %	0.04%	0.04%	0.04%	0.04%	0.05%	0.04%	-0.05%
Income Tax+	0	0	0	0	0	0	4.56M
Effective Tax Rate %	0.63%	0.69%	0.67%	0.58%	0.71%	0.63%	1.31%
Net Income+	14.68M	21.75M	19.94M	16.31M	35.42M	23.9M	-87.29M
Net Margin %	0.02%	0.03%	0.03%	0.02%	0.04%	0.02%	-0.07%
Net Income Growth %	-	0.48%	-0.08%	-0.18%	1.17%	-0.33%	-4.65%
Net Income (Continuing)	23.27M	31.37M	29.66M	28.33M	49.66M	37.72M	-71.03M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	25.86M	27.72M	28.59M	29.39M	33.2M	31.65M	7.3M
EPS (Diluted)+	0.24	0.36	0.33	0.27	0.58	0.39	-1.77
EPS Growth %	-	0.5%	-0.08%	-0.18%	1.15%	-0.33%	-5.54%
EPS (Basic)	0.24	0.36	0.33	0.27	0.58	0.39	-1.77
Diluted Shares Outstanding	60.84M	60.84M	60.84M	60.84M	60.84M	60.84M	62.01M
Basic Shares Outstanding	60.84M	60.84M	60.84M	60.84M	60.84M	60.84M	62.01M
Dividend Payout Ratio	1.56%	1.15%	0.54%	1.06%	0.87%	1.61%	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	81.23M	90.08M	93.82M	111.87M	120M	129.6M	151.99M
Cash & Short-Term Investments	2.25M	275K	6.45M	15.01M	607K	752K	4.66M
Cash Only	2.25M	275K	6.45M	15.01M	607K	752K	4.66M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	47.66M	54.21M	45.78M	55.25M	67.83M	77.26M	97.15M
Days Sales Outstanding	28.97	28.34	22.7	25.46	27.24	26.96	28.87
Inventory	27.54M	30.94M	31.93M	33.09M	41.44M	36.73M	40.55M
Days Inventory Outstanding	21.06	20.35	19.79	19.15	20.92	16	15.04
Other Current Assets	3.78M	4.66M	2.89M	8.52M	10.12M	14.86M	9.62M
Total Non-Current Assets+	100.58M	106.43M	124.05M	123.98M	136.12M	141.56M	168.82M
Property, Plant & Equipment	27.98M	35.41M	51.98M	51.72M	65.19M	73.18M	78.96M
Fixed Asset Turnover	21.46x	19.72x	14.16x	15.31x	13.94x	14.30x	15.56x
Goodwill	47.82M	46.33M	52.45M	54.63M	56.05M	56.05M	69.3M
Intangible Assets	23.82M	20.69M	19.11M	17.09M	14.44M	11.98M	14.91M
Long-Term Investments	0	0	0	0	0	0	0
Other Non-Current Assets	953K	4.01M	505K	529K	435K	358K	5.66M
Total Assets+	181.81M	196.51M	217.87M	235.85M	256.11M	271.17M	320.81M
Asset Turnover	3.30x	3.55x	3.38x	3.36x	3.55x	3.86x	3.83x
Asset Growth %	-	0.08%	0.11%	0.08%	0.09%	0.06%	0.18%
Total Current Liabilities+	65.27M	90.19M	86.35M	111.54M	112M	138.01M	144.12M
Accounts Payable	47.53M	54.93M	53.41M	64.62M	78.1M	85.6M	102.42M
Days Payables Outstanding	36.34	36.14	33.1	37.39	39.43	37.29	37.99
Short-Term Debt	2.64M	17.04M	3.63M	3.71M	7.96M	12.98M	0
Deferred Revenue (Current)	0	0	0	0	0	0	0
Other Current Liabilities	7.68M	9.94M	0	20.42M	3.62M	12.33M	16.65M
Current Ratio	1.24x	1.00x	1.09x	1.00x	1.07x	0.94x	1.05x
Quick Ratio	0.82x	0.66x	0.72x	0.71x	0.70x	0.67x	0.77x
Cash Conversion Cycle	13.69	12.55	9.39	7.21	8.73	5.66	5.92
Total Non-Current Liabilities+	48.53M	49.28M	64.44M	70.99M	68.18M	73.29M	26.71M
Long-Term Debt	36.37M	33.66M	30.74M	26.99M	22.97M	18.99M	0
Capital Lease Obligations	2.35M	3.59M	15.54M	16.12M	23.67M	27.04M	26.71M
Deferred Tax Liabilities	0	0	0	0	0	0	0
Other Non-Current Liabilities	9.81M	12.03M	18.16M	27.88M	21.54M	27.26M	0
Total Liabilities	113.8M	139.47M	150.8M	182.53M	180.18M	211.31M	170.83M
Total Debt+	43.71M	57.12M	58.84M	55.04M	62.98M	69.15M	37.33M
Net Debt	41.46M	56.84M	52.39M	40.03M	62.38M	68.4M	32.67M
Debt / Equity	0.73x	2.06x	0.88x	1.03x	0.83x	1.16x	0.25x
Debt / EBITDA	1.12x	1.14x	1.19x	1.18x	0.92x	1.17x	-
Net Debt / EBITDA	1.06x	1.14x	1.06x	0.86x	0.91x	1.16x	-
Interest Coverage	13.65x	15.15x	14.87x	18.42x	26.99x	14.32x	-19.19x
Total Equity+	59.89M	27.72M	67.07M	53.32M	75.93M	59.86M	149.98M
Equity Growth %	-	-0.54%	1.42%	-0.21%	0.42%	-0.21%	1.51%
Book Value per Share	0.98	0.46	1.10	0.88	1.25	0.98	2.42
Total Shareholders' Equity	34.03M	0	38.48M	23.93M	42.73M	28.21M	142.67M
Common Stock	34.03M	29.95M	39.15M	24.11M	42.73M	28.21M	63K
Retained Earnings	0	0	0	0	0	0	17.12M
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	-386K	-630K	-676K	-185K	0	0	0
Minority Interest	25.86M	27.72M	28.59M	29.39M	33.2M	31.65M	7.3M

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	43.67M	56.16M	52.61M	58.5M	48.52M	70.82M	57.96M
Operating CF Margin %	0.07%	0.08%	0.07%	0.07%	0.05%	0.07%	0.05%
Operating CF Growth %	-	0.29%	-0.06%	0.11%	-0.17%	0.46%	-0.18%
Net Income	23.27M	31.37M	29.66M	28.33M	49.66M	37.72M	-71.03M
Depreciation & Amortization	13.13M	15.85M	17.26M	16.53M	16.56M	18.23M	19.77M
Stock-Based Compensation	5.98M	1.93M	3.21M	13.03M	-3.38M	-6.09M	131.49M
Deferred Taxes	0	0	0	0	0	0	0
Other Non-Cash Items	2.95M	5.67M	3.58M	2.08M	4.4M	5.35M	7.14M
Working Capital Changes	-1.66M	1.34M	-1.09M	-1.47M	-18.72M	15.6M	-29.41M
Change in Receivables	-8.79M	-11.13M	3.58M	-7.71M	-16.79M	-14.3M	-25.48M
Change in Inventory	475K	-3.05M	379K	-240K	-8.12M	4.43M	-1.15M
Change in Payables	9.05M	7.91M	-1.95M	9.78M	13.37M	6.29M	13.23M
Cash from Investing+	-20.75M	-16.59M	-12.18M	-13.15M	-17.9M	-13.44M	-30.41M
Capital Expenditures	-10.01M	-14.54M	-8.34M	-9.28M	-16.77M	-14.56M	-16.37M
CapEx % of Revenue	0.02%	0.02%	0.01%	0.01%	0.02%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	-57K	16K	545K	535K	874K	2.1M	671K
Cash from Financing+	-21.07M	-41.55M	-34.26M	-36.79M	-45.03M	-57.23M	-23.64M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	-27.99M	-34.32M	-10.82M	-17.36M	-30.8M	-38.42M	-35.75M
Share Repurchases	-	-	-	-	-	-	-
Other Financing	-9.11M	-9.52M	-10.07M	-13.34M	-11.42M	-15.92M	-16.02M
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	33.67M	41.62M	44.27M	49.22M	31.75M	56.26M	41.59M
FCF Margin %	0.06%	0.06%	0.06%	0.06%	0.03%	0.05%	0.03%
FCF Growth %	-	0.24%	0.06%	0.11%	-0.35%	0.77%	-0.26%
FCF per Share	0.55	0.68	0.73	0.81	0.52	0.92	0.67
FCF Conversion (FCF/Net Income)	2.98x	2.58x	2.64x	3.59x	1.37x	2.96x	-0.66x
Interest Paid	1.83M	2.25M	2.08M	1.52M	1.78M	2.78M	3.12M
Taxes Paid	0	0	0	0	0	0	0

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	24.51%	49.64%	42.08%	27.1%	54.81%	35.2%	-83.2%
Return on Invested Capital (ROIC)	-	27.51%	23.57%	21.25%	33.66%	23.04%	-30.36%
Gross Margin	20.49%	20.54%	19.97%	20.36%	20.45%	19.91%	19.89%
Net Margin	2.44%	3.11%	2.71%	2.06%	3.9%	2.28%	-7.11%
Debt / Equity	0.73x	2.06x	0.88x	1.03x	0.83x	1.16x	0.25x
Interest Coverage	13.65x	15.15x	14.87x	18.42x	26.99x	14.32x	-19.19x
FCF Conversion	2.98x	2.58x	2.64x	3.59x	1.37x	2.96x	-0.66x
Revenue Growth	-	16.31%	5.39%	7.62%	14.75%	15.1%	17.42%

Revenue by Segment

	2024
Corporate	1.23B
Corporate Growth	-

Frequently Asked Questions

Growth & Financials

Guardian Pharmacy Services, Inc. (GRDN) reported $1.39B in revenue for fiscal year 2024. This represents a 131% increase from $600.4M in 2018.

Guardian Pharmacy Services, Inc. (GRDN) grew revenue by 17.4% over the past year. This is strong growth.

Yes, Guardian Pharmacy Services, Inc. (GRDN) is profitable, generating $40.2M in net income for fiscal year 2024 (-7.1% net margin).

Dividend & Returns

Yes, Guardian Pharmacy Services, Inc. (GRDN) pays a dividend with a yield of 1.95%. This makes it attractive for income-focused investors.

Guardian Pharmacy Services, Inc. (GRDN) has a return on equity (ROE) of -83.2%. Negative ROE indicates the company is unprofitable.

Guardian Pharmacy Services, Inc. (GRDN) generated $45.2M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.